LEIDOS BIOMEDICAL RESEARCH INC: $372M Department of Health and Human Services Contract
Summary
Leidos Holdings ($LDOS) wins a $372M task order from NIH for NCI operations, adding ~2.4% to annual revenue. The award is a routine renewal under an existing contract, providing stable cash flow but no transformative catalyst.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Leidos adds $372M to its backlog, representing ~2.4% of annual revenue.
- 2.The award is a routine renewal under an existing NIH contract, not a new program.
- 3.No direct legislative catalyst; funding comes from NIH appropriations.
Market Implications
For Leidos, this contract is a positive but expected development. The stock is already priced for steady government contracting, so the award is unlikely to drive significant price movement. It confirms the company's reliable cash flow from health IT and research support. No other publicly traded companies are directly impacted.
Full Analysis
The Department of Health and Human Services, through the National Institutes of Health, awarded Leidos Biomedical Research Inc a $372M delivery order for NCI operational support covering FY2026-FY2027. This is a task order under an existing contract, indicating continued partnership rather than new business. Leidos Holdings is the publicly traded parent, with FY2025 revenue of $15.3B. The $372M represents 2.4% of annual revenue, a meaningful but not transformative addition. No specific legislation is directly tied to this award; it is funded through NIH's base appropriations. Supply chain beneficiaries are likely small businesses in health IT and laboratory services, but no publicly traded subcontractors are identified. Historically, Leidos has consistently won large NIH contracts, and this award continues that pattern without shifting competitive dynamics.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
LEIDOS BIOMEDICAL RESEARCH INC: $485M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $826M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Streamlining Access to Government Services Through America.gov
The executive order directs the General Services Administration to create America.gov, a unified digital portal for federal services, integrating Login.gov for authentication and requiring agencies to expose their digital services via APIs. It also mandates the use of AI (referred to as 'super intelligence') with transparency safeguards, while preserving existing service channels and excluding tax and defense/intelligence services.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Restriction on Entry of Certain Nonimmigrant Workers
This proclamation extends for an additional 12 months the existing restriction on entry of H-1B nonimmigrant workers, which requires a $100,000 payment per petition (with limited exceptions) and is supported by a DHS weighted selection process that prioritizes higher-skilled, higher-paid workers. The action continues to target IT staffing and outsourcing firms that have abused the program, and it maintains the requirement for ongoing rulemakings by DHS and DOL to further reform wage protections and program integrity.
Contract Details
Recipient
LEIDOS BIOMEDICAL RESEARCH INC
Award Amount
$371,787,375
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
DELIVERY ORDER
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →